Associate Professor Gerald Fogarty

Clinical Associate Professor
Medicine, Northern Clinical School

Telephone +61 2 9458 8000
Fax +61 2 9458 8088

Map

Selected grants

2013

  • The cost-effectiveness of adjuvant whole brain radiotherapy for melanoma brain metastases: a trial-based and modeled economic evaluation; Morton R, King M, Fogarty G, Nowak A, Hong A; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.

2011

  • Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma - a randomised phase III trial; Fogarty G, Burmeister B, Drummond K, Thompson J, Hong A; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.

2008

  • WBRT: Whole Brain Radiotherapy following local treatment of intracranial mestastases of melanoma = a randomised phase III trial; Fogarty G; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.
  • Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma - a randomised phase III trial; Fogarty G; University of Sydney/Bridging Support.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Fogarty, G., Hong, A., Dolven Jacobsen, K., Reisse, C., Shivalingam, B., Burmeister, B., Haydu, L., Paton, E., Thompson, J. (2014). Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible. BMC Research Notes, 7(13), 1-7. [More Information]
  • Guitera, P., Haydu, L., Menzies, S., Scolyer, R., Hong, A., Fogarty, G., Gallardo, F., Segura, S. (2014). Surveillance for treatment failure of lentigo maligna with dermoscopy and in vivo confocal microscopy: new descriptors. British Journal of Dermatology, 170(6), 1305-1312. [More Information]
  • Awad, R., Fogarty, G., Hong, A., Kelly, P., Ng, D., Santos, D., Haydu, L. (2013). Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases - the first Australian experience. Radiation Oncology, 8(1), 1-6. [More Information]
  • Fogarty, G., Guminski, A., Shannon, K. (2013). How important is multidisciplinary treatment of melanoma metastases? Expert Review of Dermatology, 8(4), 339-341. [More Information]
  • Thompson, J., Hong, A., Fogarty, G. (2012). Publication and Interpretation of Clinical Trial Results: The Need for Caution. Annals of Surgical Oncology, 19(6), 1745-1747. [More Information]
  • Sung-In Jang, H., Spillane, A., Boyle, F., Fogarty, G. (2012). Radiotherapy can cause haemostasis in bleeding skin malignancies. Case Reports in Medicine, 2012, 168681- 1-168681- 4. [More Information]
  • Hong, A., Fogarty, G. (2012). Role of radiation therapy in cutaneous melanoma. The Cancer Journal, 18(2), 203-207. [More Information]
  • Hong, A., Fogarty, G., Izard, M. (2012). The Role of Radiation Therapy in the Management of Metastatic Melanoma in the Brain. International Journal of Surgical Oncology, 2012, 1-6. [More Information]
  • Carlino, M., Fogarty, G., Long, G. (2012). Treatment of Melanoma Brain Metastases: A New Paradigm. The Cancer Journal, 18(2), 208-212. [More Information]
  • Seymour, E., Downes, S., Fogarty, G., Izard, M., Metcalfe, P. (2011). In vivo real-time dosimetric verification in high dose rate prostate brachytherapy. Medical Physics, 38(8), 4785-4794. [More Information]
  • Fogarty, G., Ng, D., Liu, G., Haydu, L., Bhandar, N. (2011). Volumetric modulated arc therapy is superior to conventional intensity modulated radiotherapy - a comparison among prostate cancer patients treated in an Australian centre. Radiation Oncology, 6(September), 1-5. [More Information]
  • Fogarty, G. (2007). Six-year experience of external beam radiotherapy, brachytherapy boost with a 1mCi Ir-192 source and neoadjuvant hormonal manipulation for prostate cancer. BJU International, 99(2), 7-8.
  • Fogarty, G., Cassumbhoy, R., Ball, D. (2006). Magnetic resonance imaging changes in synchronous bilateral progressive facial nerve weakness. Journal of Thoracic Oncology, 1(5), 487-8. [More Information]
  • Izard, M., Haddad, R., Fogarty, G., Rinks, A., Dobbins, T., Katelaris, P. (2006). Six year experience of external beam radiotherapy, brachytherapy boost with a 1Ci (192)Ir source, and neoadjuvant hormonal manipulation for prostate cancer. International Journal of Radiation: Oncology - Biology - Physics, 66(1), 38-47. [More Information]

2014

  • Fogarty, G., Hong, A., Dolven Jacobsen, K., Reisse, C., Shivalingam, B., Burmeister, B., Haydu, L., Paton, E., Thompson, J. (2014). Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible. BMC Research Notes, 7(13), 1-7. [More Information]
  • Guitera, P., Haydu, L., Menzies, S., Scolyer, R., Hong, A., Fogarty, G., Gallardo, F., Segura, S. (2014). Surveillance for treatment failure of lentigo maligna with dermoscopy and in vivo confocal microscopy: new descriptors. British Journal of Dermatology, 170(6), 1305-1312. [More Information]

2013

  • Awad, R., Fogarty, G., Hong, A., Kelly, P., Ng, D., Santos, D., Haydu, L. (2013). Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases - the first Australian experience. Radiation Oncology, 8(1), 1-6. [More Information]
  • Fogarty, G., Guminski, A., Shannon, K. (2013). How important is multidisciplinary treatment of melanoma metastases? Expert Review of Dermatology, 8(4), 339-341. [More Information]

2012

  • Thompson, J., Hong, A., Fogarty, G. (2012). Publication and Interpretation of Clinical Trial Results: The Need for Caution. Annals of Surgical Oncology, 19(6), 1745-1747. [More Information]
  • Sung-In Jang, H., Spillane, A., Boyle, F., Fogarty, G. (2012). Radiotherapy can cause haemostasis in bleeding skin malignancies. Case Reports in Medicine, 2012, 168681- 1-168681- 4. [More Information]
  • Hong, A., Fogarty, G. (2012). Role of radiation therapy in cutaneous melanoma. The Cancer Journal, 18(2), 203-207. [More Information]
  • Hong, A., Fogarty, G., Izard, M. (2012). The Role of Radiation Therapy in the Management of Metastatic Melanoma in the Brain. International Journal of Surgical Oncology, 2012, 1-6. [More Information]
  • Carlino, M., Fogarty, G., Long, G. (2012). Treatment of Melanoma Brain Metastases: A New Paradigm. The Cancer Journal, 18(2), 208-212. [More Information]

2011

  • Seymour, E., Downes, S., Fogarty, G., Izard, M., Metcalfe, P. (2011). In vivo real-time dosimetric verification in high dose rate prostate brachytherapy. Medical Physics, 38(8), 4785-4794. [More Information]
  • Fogarty, G., Ng, D., Liu, G., Haydu, L., Bhandar, N. (2011). Volumetric modulated arc therapy is superior to conventional intensity modulated radiotherapy - a comparison among prostate cancer patients treated in an Australian centre. Radiation Oncology, 6(September), 1-5. [More Information]

2007

  • Fogarty, G. (2007). Six-year experience of external beam radiotherapy, brachytherapy boost with a 1mCi Ir-192 source and neoadjuvant hormonal manipulation for prostate cancer. BJU International, 99(2), 7-8.

2006

  • Fogarty, G., Cassumbhoy, R., Ball, D. (2006). Magnetic resonance imaging changes in synchronous bilateral progressive facial nerve weakness. Journal of Thoracic Oncology, 1(5), 487-8. [More Information]
  • Izard, M., Haddad, R., Fogarty, G., Rinks, A., Dobbins, T., Katelaris, P. (2006). Six year experience of external beam radiotherapy, brachytherapy boost with a 1Ci (192)Ir source, and neoadjuvant hormonal manipulation for prostate cancer. International Journal of Radiation: Oncology - Biology - Physics, 66(1), 38-47. [More Information]

To update your profile click here. For support on your academic profile contact .